Arena Pharmaceuticals (ARNA) 24.37 green arrow $0.40 (1.67%) 12:31AM (15 mins delay)


ARNA Inc

Stock Picks

stock pick type FDA Approval Play
Posted 3013 days ago on 4/24/09 by Mr. Krabs

ARNA's lorcaserin hydrochloride, the obesity treatment drug is being reviewed by FDA following a Phase III clinical trial program that determined that allegedly was very successful with no significant...

Read complete stock pick on ARNA

stock pick type Lets make a deal
Posted 3217 days ago on 10/02/08 by Fundave Dpbkmb

I think that Merck recently giving up on its diet drug because of adverse effects is good news for Arena. Merck has collaborated with Arena before and I'm sure that they have been watching the development...

Read complete stock pick on ARNA

stock pick type Arena moving on up?
Posted 3314 days ago on 6/27/08 by Fundave Dpbkmb

FYI, there was an analyst on CNBC yesterday that recommended Arena, ARNA, a longtime holding of mine, and the stock finished up in a Dow down 350 market. It is also now up, in a down market, over 10%...

Read complete stock pick on ARNA

stock pick type Blockbuster Obese Pill in Phase III Trials.
Posted 3512 days ago on 12/12/07 by Chris Katje

Arena Pharmaceuticals has a potential blockbuster drug (Lorcaserin) in phase III trials. The drug is expected to be decided by the FDA in 2010. There have been no problems in a six month trial and...

Read complete stock pick on ARNA

stock pick type More safety reviews to push the stock higher
Posted 3602 days ago on 9/13/07 by Alex Genadinik

There will be a safety review of Arena's leading drug with newest results coming out every six months. In addition to that in late 07 and early 08 there will be news concerning two of the company's other...

Read complete stock pick on ARNA

Subscribe to Stock Picks feed:
Displaying 1 - 5 of 5

ARNA
$24.37    $0.40  (1.67%)

ARNA Inc

sharewise



Make a suggestion for this page